|
|
 |
|
 |
 |
"The addition of Sicor as a partner supplements OA's already robust portfolio of products and provides more variety for the future needs of our physicians."
- Dennis Wollschleger
- Chief Executive Officer, Oncology Associates |
 |
 |
|
|
 |
|
|
 |
 |
 |
|
 |
| SICOR Inc. is a vertically integrated, multinational pharmaceutical company that focuses on generic finished dosage injectable pharmaceuticals, active pharmaceutical ingredients, or APIs, and generic biopharmaceuticals. Using internal research and development capabilities, together with operational flexibility and manufacturing and regulatory expertise, SICOR is able to take a wide variety of products from the laboratory to the worldwide market. Leveraging these capabilities, SICOR concentrates on products and technologies that present significant barriers to entry or offer first-to-market opportunities. |
|
| SICOR offers a wide variety of generic drugs including but not limited to: |
 |
ADRUCIL® Injection
Fludarabine for Injection
IDArubicin Hydrochloride Injection
Ifosfamide/Mesna Kit
Leuprolide Acetate
Mesna Injection
Vinorelbine Tartrate
|
|
 |
 |
|
